In the wake of the federal government’s marijuana rescheduling announcement last week that acknowledged the medical benefits of cannabis, the Drug Enforcement Administration (DEA) on Thursday released a report that appears to question the legitimacy of state medical programs.
“Marijuana remains illegal at the federal level; it has been ‘legalized’ or ‘decriminalized’ at the state level for recreational use in 24 states and the District of Columbia, and for ‘medical’ use in 38 states and the District of Columbia,” the annual National Drug Threat Assessment says, appearing to call those state-level changes and the medical value of cannabis into question by putting scare quotes around key words.
That’s despite the fact that DEA recently agreed to a Department of Health and Human Services recommendation to move cannabis to Schedule III of the Controlled Substances Act, acknowledging for the first time that cannabis has an accepted medical use in the U.S.
The comments make up only a small part of the 57-page annual report, which the agency said analyzes “illicit drug threats and trafficking trends endangering the United States.”
The top-level findings, according to a statement from DEA Administrator Anne Milgram, are that the country’s shift toward synthetic substances such as fentanyl and methamphetamine—which she blamed largely on international cartels—has caused unprecedented harm.
“The shift from plant-based drugs, like heroin and cocaine, to synthetic, chemical-based drugs, like fentanyl and methamphetamine, has resulted in the most dangerous and deadly drug crisis the United States has ever faced,” Milgram said. “At the heart of the synthetic drug crisis are the Sinaloa and Jalisco cartels and their associates, who DEA is tracking world-wide.”
“The suppliers, manufacturers, distributors, and money-launderers all play a role in the web of deliberate and calculated treachery orchestrated by these cartels,” her statement continued. “DEA will continue to use all available resources to target these networks and save American lives.”
In 2022, drug-related deaths killed 107,941 people in the United States, DEA said in its press release about the new assessment. “Fentanyl and other synthetic opioids are responsible for approximately 70% of lives lost,” it says, “while methamphetamine and other synthetic stimulants are responsible for approximately 30% of deaths.”
The agency press release doesn’t mention marijuana, though this year’s National Drug Threat Assessment itself does include some cannabis-related details.
Hellbound and Down 